Tiziana Life Sciences Ltd (TLSA) News
Track canonical SquawkNews coverage tagged to TLSA, Tiziana Life Sciences Ltd. This hub brings together deduplicated headlines about alpaca us equities, markets catalysts, earnings, analyst actions, and wider market events so traders can review how a developing story changed over time. It contains 11 indexed stories across 8 publication days and is ordered by the same first-publication timeline used by LiveCast.
M
Tiziana says last patient completed last visit in phase 2A trial
Tiziana Life Sciences said the last patient completed the last visit in its Phase 2A Inform-MS trial of intranasal foralumab.
EQUITY | Sep 21, 2026, 12:07 PM UTC
L
TLSA - Tiziana Announces Last Patient Completes Last Visit in Phase 2a INFORM-MS Trial of Intranasal Foralumab
TLSA - Tiziana Announces Last Patient Completes Last Visit in Phase 2a INFORM-MS Trial of Intranasal Foralumab
NEWS | Sep 21, 2026, 11:00 AM UTC
L
TLSA - Tiziana Life Sciences Announces Signing of MOU with King Abdullah International Medical Research Center
TLSA - Tiziana Life Sciences Announces Signing of MOU with King Abdullah International Medical Research Center
NEWS | Sep 17, 2026, 11:00 AM UTC
L
Tiziana Life Sciences Initiated at Buy by BTIG
Ratings actions from Benzinga
EQUITY | Sep 03, 2026, 10:18 AM UTC
L
Tiziana Life Sciences to present Phase 2a BANYAN poster
Tiziana Life Sciences (TLSA) announces a poster presentation at ALS Nexus 2026 covering its Phase 2a BANYAN clinical trial of intranasal foralumab.
EQUITY | Aug 24, 2026, 11:00 AM UTC
L
Tiziana Life Sciences CEO Elrifi Sells 321,423 Shares
Tiziana Life Sciences CEO sells shares
EQUITY | Aug 06, 2026, 01:31 PM UTC
L
Tiziana Life Sciences CEO Buys Shares
CEO purchases company shares
EQUITY | Aug 06, 2026, 11:01 AM UTC
H
Insiders Buy $13M+ in BSX, HLI, IR, PFE, WCC, TLSA, TSCO
Insiders purchase over $13 million in company shares
EQUITY | Aug 06, 2026, 09:19 AM UTC
L
Tiziana Life Sciences CEO Buys Shares
CEO purchases company shares
EQUITY | Aug 04, 2026, 11:01 AM UTC
H
TLSA Reports Reduction in Brain Inflammation
TLSA treats third patient with reduced brain inflammation
EQUITY | Jul 31, 2026, 11:00 AM UTC
M
TLSA Completes Dosing
Tiziana announces last patient successfully dosed in its Phase 2 INFORM-MS trial
EQUITY | Jun 25, 2026, 11:00 AM UTC